Author Name: Morgan E

Category Name: Diabetes

Description:

Gestational diabetes is a condition in which a woman without diabetes develops high blood sugar levels during pregnancy. Gestational diabetes generally results in few symptoms; however, it does increase the risk of pre-eclampsia, depression, and requiring a Caesarean section. Babies born to mothers with poorly treated gestational diabetes are at increased risk of being too large, having low blood sugar after birth, and jaundice. If untreated, it can also result in a stillbirth. Long term, children are at higher risk of being overweight and developing type 2 diabetes.

Gestational diabetes can occur during pregnancy because of insulin resistance or reduced production of insulin. Risk factors include being overweight, previously having gestational diabetes, a family history of type 2 diabetes, and having polycystic ovarian syndrome. Diagnosis is by blood tests.  For those at normal risk, screening is recommended between 24 and 28 weeks' gestation. For those at high risk, testing may occur at the first prenatal visit.

Prevention is by maintaining a healthy weight and exercising before pregnancy. Gestational diabetes is treated with a diabetic diet, exercise, medication (such as metformin), and possibly insulin injections. Most women are able to manage their blood sugar with diet and exercise. Blood sugar testing among those who are affected is often recommended four times a day. Breastfeeding is recommended as soon as possible after birth.

Gestational diabetes affects 3–9% of pregnancies, depending on the population studied. It is especially common during the last three months of pregnancy. It affects 1% of those under the age of 20 and 13% of those over the age of 44.A number of ethnic groups including Asians, American Indians, Indigenous Australians, and Pacific Islanders are at higher risk. In 90% of cases, gestational diabetes will resolve after the baby is born. Women, however, are at an increased risk of developing type 2 diabetes.

Journal of Clinical Diabetes is a peer-reviewed journal that aims to publish research dealing with Diabetes research such as: Type 1 and Type 2 Diabetes, Diabetic Nephropathy and retinopathy, Gestational Diabetes and covers all aspects of diabetes technology including: insulin and metabolic peptide delivery, glucose monitoring, Prediabetes, Latent autoimmune diabetes of adults etc.

Submit manuscript at   https://www.scholarscentral.org/submissions/clinical-diabetes.html

or send as an e-mail attachment to the Editorial Office at clindiabetes@eclinicalsci.com

Regards,
Morgan E,
Editiorial Manager,
Journal of Clinical Diabetes.

E-mail: clindiabetes@eclinicalsci.com